A detailed history of Close Asset Management LTD transactions in Novavax Inc stock. As of the latest transaction made, Close Asset Management LTD holds 50 shares of NVAX stock, worth $413. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$413
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$3.89 - $20.97 $194 - $1,048
50 New
50 $1,000
Q1 2023

Apr 19, 2023

SELL
$5.76 - $12.48 $20,736 - $44,928
-3,600 Reduced 74.07%
1,260 $9,000
Q4 2022

Jan 27, 2023

SELL
$8.86 - $25.04 $30,123 - $85,136
-3,400 Reduced 41.16%
4,860 $50,000
Q3 2022

Oct 26, 2022

SELL
$18.2 - $76.12 $20,202 - $84,493
-1,110 Reduced 11.85%
8,260 $151,000
Q2 2022

Jul 29, 2022

BUY
$36.28 - $75.29 $339,943 - $705,467
9,370 New
9,370 $482,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $647M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Close Asset Management LTD Portfolio

Follow Close Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.